GDC-0425
GDC-0425 Uses, Dosage, Side Effects, Food Interaction and all others data.
GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma).
| Trade Name | GDC-0425 |
| Generic | GDC-0425 |
| Type | |
| Formula | C18H19N5O |
| Weight | Average: 321.384 Monoisotopic: 321.158960252 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here GDC-0425
